[1] |
LU Tingting, SHI Lijun, LIU Yingzhao, LIANG Huiting, WANG Qi.
Down⁃regulation of α2⁃macroglobulin expression activates TGF⁃β/SMADs signaling pathway to induce cisplatin resistance in ovarian cancer
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(6): 707-714.
|
[2] |
LIANG Yuanzheng, WANG Henan, WANG Liang.
Effects of PPP2R5C on proliferation, apoptosis, and drug sensitivity of multiple myeloma cells
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(4): 405-411.
|
[3] |
LI Nan, LU Chenyang, ZHU Ani, YANG Dongcai, MA Qian, YAN Fengqi, JIA Weihong.
Effects of glycolysis in Gefitinib resistance in non⁃small cell lung cancer
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(1): 50-55.
|
[4] |
WU Min, JIN Mengmeng, CAO Xiaohui, Li Yonghuai.
Effect of combining anlotinib with gefitinib on proliferation of non⁃small cell lung cancer PC9/GR cells and its possible mechanism
[J]. Chinese Journal of Oncology Prevention and Treatment, 2022, 14(5): 503-508.
|
[5] |
CHEN Chaomei, XI Min, SHI Xiu, WANG Fang, ZHOU Jinhua.
Effect of silencing G6PD on cisplatin sensitivity of ovarian cancer cells and its mechanism
[J]. Chinese Journal of Oncology Prevention and Treatment, 2022, 14(3): 274-280.
|
[6] |
CHU Wenmei, XIONG Xudong, HE Miao, JI Gaorong, CHEN Liyun, TONG Jia, ZHANG Zhuocheng, LI Li.
Effect of resveratrol on biological effects of human gastric cancer SGC-7901/5-FU cells and its mechanisms
[J]. Chinese Journal of Oncology Prevention and Treatment, 2021, 13(3): 231-236.
|
[7] |
BIAN Weigang, CHEN Ping, ZHOU Xiaoning, CHEN Haiting, SONG Shu.
LncRNA SNHG1 targets miR-101-3p to regulate oxaliplatin resistance in gastric cancer cells
[J]. Chinese Journal of Oncology Prevention and Treatment, 2021, 13(3): 242-247.
|
[8] |
LIU Ying, FENG Dabing, WANG Jizhao, ZHANG Cheng, ZHANG Lu, ZHANG Mingxin, CHEN Nanzheng.
Matrine-inhibiting radiation resistance in esophageal squamous cell carcinoma by inducing miR-433-3p expression
[J]. Chinese Journal of Oncology Prevention and Treatment, 2021, 13(1): 34-39.
|
[9] |
YUAN Hao, ZHONG Huage, YAN Linhai, TANG Weizhong .
A bioinformatics-based analysis of immune resistance modes mediated by high frequency mutation of STIM1 in colorectal cancer and related molecular mechanisms
[J]. Chinese Journal of Oncology Prevention and Treatment, 2020, 12(5): 566-571.
|
[10] |
HE Shan, DENG Lu, CAI Zhifu, ZHANG Jieqing, LI Li.
Effect of adiponectin on the growth of insulin resistance endometrial cancer xenografts in nude mice induced by high-fat diet
[J]. Chinese Journal of Oncology Prevention and Treatment, 2020, 12(2): 186-190.
|
[11] |
SHA Yutong, HUANG Jiaming, LU Zhenping, LIANG Huan, ZHENG Zongmei, YANG Xuepan, SHI Hongfei, ZHU Mingming.
Vitamin D inhibited breast cancer stem cells through Wnt/β-catenin signaling pathway
[J]. Chinese Journal of Oncology Prevention and Treatment, 2019, 11(4): 297-302.
|
[12] |
YAN Linhai, JIN Qinwen, QIN Yuzhou, CHEN Jiansi, ZHONG Huage, TANG Weizhong.
Effects of over-expression E2F1 gene on multi-drug resistance of human colon cancer Oxaliplatin-resistant cell line HCT116/L
[J]. Chinese Journal of Oncology Prevention and Treatment, 2019, 11(1): 30-36.
|
[13] |
Jin Mingpeng,Yin Chun,Shang Yingying,Cao Haiyan,Ji Xiaoying,Ren Tingting,Xing Jinliang,Wu Yousheng.
Effect of NCLX-mediated mitochondrial calcium homeostasis on the growth of hepatocellular carcinoma cells
[J]. Chinese Journal of Oncology Prevention and Treatment, 2018, 10(6): 420-426.
|
[14] |
Zhao Lingyun,You Xuemei,Wei Jueling,Zhao Xinhua,Tang Juan,Li Qiuqin,Luo mei.
Effect of short-term structural psychological education intervention combined with Xiaoyaosan on moderate and severe depression in patients with hepatocellular carcinoma during periop-erative period
[J]. Chinese Journal of Oncology Prevention and Treatment, 2018, 10(6): 473-478.
|
[15] |
Tan Ni,Cao Ji,Yang Chun,Zheng Haiping,Ou Chao.
Analysis of the alternative splicing events of AFB1-induced liver cancer in rats based on RNA-seq
[J]. Chinese Journal of Oncology Prevention and Treatment, 2018, 10(5): 356-360.
|